Müller-Sieburg, Christa E.
Christa E Müller investigadora
Müller-Sieburg, C. (Christa)
Müller, Christa E.
Müller-Sieburg, C.
Mueller-Sieburg, Christa E.
VIAF ID: 30203959 (Personal)
Permalink: http://viaf.org/viaf/30203959
Preferred Forms
- 100 0 _ ‡a Christa E Müller ‡c investigadora
-
- 100 1 _ ‡a Müller, Christa E.
-
- 100 1 _ ‡a Müller-Sieburg, C. ‡q (Christa)
- 100 1 _ ‡a Müller-Sieburg, Christa E.
-
- 100 1 _ ‡a Müller-Sieburg, Christa E
-
- 100 1 _ ‡a Müller-Sieburg, Christa E.
4xx's: Alternate Name Forms (12)
Works
Title | Sources |
---|---|
Chromenones as Multineurotargeting Inhibitors of Human Enzymes | |
Design, synthesis and pharmacological evaluation of nucleotidic and non-nucleotidic inhibitors and probes for the ecto-5'-nucleotidase (CD73) | |
Epibatidin - ein nicotinartiges, analgetisch wirksames Alkaloid aus Pfeilgiftfröschen | |
Erratum to: Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma. | |
Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides | |
The experimental power of FR900359 to study Gq-regulated biological processes | |
Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis | |
Extracellular NAD(+) induces a rise in [Ca(2+)](i) in activated human monocytes via engagement of P2Y(1) and P2Y(11) receptors | |
Fast, efficient capillary electrophoresis method for measuring nucleotide degradation and metabolism | |
Fluorescent-labeled selective adenosine A2B receptor antagonist enables competition binding assay by flow cytometry. | |
Focused screening to identify new adenosine kinase inhibitors | |
The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects | |
Hematopoietic stem cells : animal models and human transplantation | |
Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum. | |
Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1). | |
Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP. | |
Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties. | |
Improving Potency, Selectivity, and Water Solubility of Adenosine A1 Receptor Antagonists: Xanthines Modified at Position 3 and Related Pyrimido[1,2,3-cd]purinediones | |
Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models | |
Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency | |
Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors. | |
Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism. | |
Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication | |
Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila | |
Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor | |
Interaction of Purinergic P2X4 and P2X7 Receptor Subunits | |
Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity | |
Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors | |
International conference on purinergic drugs and targets-4th joint german-italian purine club meeting, bonn, Germany, july 22-25, 2011. | |
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | |
Investigation on 2',3'-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists | |
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats | |
Involvement of GPR17 in Neuronal Fibre Outgrowth | |
Iodine-catalyzed electrophilic substitution of indoles: Synthesis of (un)symmetrical diindolylmethanes with a quaternary carbon center | |
Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680. | |
Large-volume sample stacking with polarity switching for monitoring of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) reactions by capillary electrophoresis | |
Ligand-specific binding and activation of the human adenosine A(2B) receptor. | |
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors | |
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. | |
The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis | |
Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling | |
Medicinal chemistry of adenosine, P2Y and P2X receptors | |
Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. | |
Microwave-assisted ring closure reactions: synthesis of 8-substituted xanthine derivatives and related pyrimido- and diazepinopurinediones | |
Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information | |
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor. | |
Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen. | |
The natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonists | |
A new, sensitive ecto-5'-nucleotidase assay for compound screening. | |
The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. | |
Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative | |
Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B | |
A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide | |
The nucleobase adenine as a signalling molecule in the kidney. | |
Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase. | |
Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. | |
Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. | |
Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX. | |
P2-pyrimidinergic receptors and their ligands | |
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus. | |
P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction. | |
P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivo | |
P2Y2 receptor modulates shear stress-induced cell alignment and actin stress fibers in human umbilical vein endothelial cells | |
Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. | |
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice | |
Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: Structure–activity relationships as adenosine A1 and A2A receptor ligands | |
The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413. | |
Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase | |
Receptor-mediated activation and pharmacological inhibition of heterotrimeric G proteins | |
Regulation der Expression idiotopischer Antikörper durch Isotyp-Varianten von monoklonalen anti-idiotopischen Antikörpern | |
Stereochemie und Arzneistoffe | |
Sulfated Polysaccharides from Macroalgae Are Potent Dual Inhibitors of Human ATP-Hydrolyzing Ectonucleotidases NPP1 and CD39 | |
Synthese und Eigenschaften chiraler Amphiphile und liposomaler Prodrugs mit unsymmetrisch substituierter Disulfidbrücke | |
Synthesis and structure-activity relationships of CD39 and CD73 inhibitors | |
Synthesis, structure and benzodiazepine receptor binding |